Deferasirox

Details

Files

Generic Name:

Deferasirox

Project Status:

Complete

Therapeutic Area:

Iron overload

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Brand Name:

Exjade

Project Line:

Reimbursement Review

Project Number:

SR0081-000

Submission Type:

Initial

Indications:

Iron overload

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

April 19, 2007

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 26, 2006